Table 2.
Five-year survivals (5YS) in resected non-small-cell carcinoma subtypes (all resected stages).
| Squamous-cell carcinoma (%) | Adenocarcinoma (%) | Large-cell carcinoma | Adenosquamous carcinoma | |
|---|---|---|---|---|
| Pfannschmidt et al., 2007 [35]n = 2376 cases | 53.6 | 48.2 | 45.8 | – |
| Asamura et al., 2008 [36]n = 13,010 cases | 52.5 | 67.3a | 45.5 | 42.1 |
| Chansky et al., 2009 [12]n = 9137 cases | 43 | 44b | 41 | 29 |
a
These cases would include adenocarcinoma in situ (AIS).
b
This is the 5YS for adenocarcinomas excluding those diagnosed as ‘BAC’(see text). Given variations in stage distribution and other potential confounding factors, comparison between cell types within studies are probably more meaningful than those between studies.